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Traditional medicinal trade in South Africa is a lucrative enterprise, estimated to be worth in excess of R3 billion, representing roughly 6% of
the National Health budget. With approximately 27 million consumers, a rich local ﬂoral biodiversity platform and a substantial base of traditional
medicinal knowledge, its impact and growth potential has not gone unnoticed by the South African government. In this regard, several draft policy
bills have passed through parliament to facilitate the integration of traditional medicine into the mainstream South African healthcare system. De-
spite these measures, trade in traditional medicine remains fragmented and largely unregulated. The present ﬁndings highlight this aspect of the
industry via identiﬁcation of the common plasticizer di(2-ethylhexyl) phthalate (DEHP) in a local cognate herbal remedy. Given the highly toxic
nature of this substance and the strict international controls in place for regulation of its consumption, the amount of DEHP isolated (43.3 mg/L)
from the mixture was seen to be unacceptably high. These observations raise further questions pertaining to quality, safety and efﬁcacy structures
within the traditional medicine sector.
© 2012 SAAB. Published by Elsevier B.V. All rights reserved.
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The southern African region is home to an abundant floral
diversity comprising some 30000 species, representing at
least 10% of the world's flowering plant population
(Goldblatt, 1978). The use of many of these plants in the tradi-
tional medicinal practice systems of the indigenous peoples of
the area has been known for several centuries (Watt and
Breyer-Brandwijk, 1962). Conservative estimates have put aAbbreviations: COSY, correlation spectroscopy; EI, electron impact;
HMBC, heteronuclear multiple bond correlation; HRMS, high resolution mass
spectroscopy; HSQC, heteronuclear spin quantum correlation; LRMS, low res-
olution mass spectroscopy; NMR, nuclear magnetic resonance; TM, traditional
medicine.
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doi:10.1016/j.sajb.2012.01.008figure of around 1000 to the number of ethnomedicinal plant
taxa currently exploited in the South African traditional health-
care sector (Arnold et al., 2000). As a consequence, many
related scientific investigations have been guided by the rich
oral tradition of ethnic medicine, in conjunction with the sub-
stantial base of traditional medicinal knowledge which has
appeared in the literature over the past two decades (Light et
al., 2005). Such endeavors have propelled the potential of our
local biodiversity onto the international stage, catalysed by
the commercialization of several endemic species such as
Aloe ferox, Agathosma betulina, Harpagophytum procumbens,
Sutherlandia frutescens and Hoodia gordonii as global herb-
al remedies for diverse medical conditions (Van Wyk,
2002).
Trade in traditional medicines (TMs) in South Africa is a vi-
brant, widespread and lucrative enterprise, estimated to be
worth in excess of R3 billion, representing roughly 6% of the
National Health budget (Mander, 1998). With approximatelyreserved.












Fig. 2. Structure of phthalate diester isolated from ‘Sejeso’ herbal mixture
(Ingwe® brand).
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133000, largely, rural women employees, the TM plant trade is
a key industrial and business incubator (Williams et al., 2000).
The reliance of such a large proportion of the population on TM
for primary health care needs has been attributed to a number of
factors, including availability and accessibility to plant materi-
al, affordability, and extensive traditional knowledge and ex-
pertise within local communities (Fennell et al., 2004).
Contrary to popular belief, use of TMs occurs across all sectors
of the consumer population and is not confined to the poor,
rural or uneducated end of the market (Mander et al., 2007).
Furthermore, a recent study has shown that 97% of patients
consulting traditional healers do so out of choice, rather than is-
sues associated with access and cost of western medicine
(Mander et al., 2007).
Given the expanse and potential of TM trade, the South Af-
rican government, in line with World Health Organization
(WHO), African Union (AU) and Southern African Develop-
ment Community (SADC) initiatives, has formulated a pro-
gram for integration of African Traditional Medicine (ATM)
into the mainstream South African healthcare system
(Government Gazette No. 31271, 2008). Towards this end,
the Directorate of Traditional Medicine was established in
2006 to co-ordinate and manage initiatives within the Depart-
ment of Health, as well as to facilitate the Traditional Practi-
tioners Act (No. 22 of 2007) (Government Gazette No.
30660, 2008). Further to this, greater responsibility towards
TMs was encouraged within statutory bodies such as the Coun-
cil for Scientific and Industrial Research (CSIR), Medical Re-
search Council (MRC) and Medicines Control Council
(MCC). Despite these far-reaching measures, trade in TM in
South Africa remains largely unregulated and as such raises se-
rious questions about quality, safety and efficacy structures
within the sector (Street et al., 2008).
Against this backdrop, we became interested in elucidating
the pharmacological basis to the usage of popular herbal prepa-
rations available commercially on the local TMmarket in Pieter-
maritzburg (Ndhlala et al., 2010a,b, 2011a,b). Not surprisingly,
this work uncovered the potential of several herbal preparations
as antioxidant and antimicrobial agents, as well as inhibitors of
the enzymes HIV-1 reverse transcriptase and acetylcholinester-
ase (Ndhlala et al., 2010b, 2011a). Despite these promising
pharmacological profiles, several of these preparations were
seen to possess in vitro cytotoxic and mutagenic properties,
thus cautioning against their extended use (Ndhlala et al.,
2010a, 2011a). As a consequence of its broad observed pharma-
cological profile (Ndhlala et al., 2010b), ‘Sejeso’ herbal mixture
(Ingwe® brand) (Fig. 1) was here selected for phytochemical in-
vestigation to elucidate the underlying active constituents. In
the process, the known commercial plasticizer di(2-ethyl-
hexyl) phthalate (DEHP) (Fig. 2) was isolated at a concentra-
tion of 43.3 mg/L from the preparation and identified by
spectroscopic means, including 2D NMR techniques. The
presence of this well-known toxic substance in the cognate
mixture, and at such high levels, is alarming and raises ques-
tions pertaining to quality control measures within the TM
sector.2. Materials and methods
2.1. General
IR spectra were measured on a Bio-Rad FTS-40 series spec-
trometer in dry film. EIMS were run on a Micromass Quattro
Ultima spectrometer fitted with a direct injection probe (DIP)
with ionization energy set at 70 eV and HRMS (EI) were per-
formed with a Micromass Q-Tof Ultima spectrometer. 1H and
13CNMR, DEPT, COSY, HSQC and HMBC spectra were
recorded on a Bruker AV400 spectrometer in CDCl3, chemical
shifts are reported in units of δ (ppm) and coupling constants
(J) are expressed in Hz. Silica gel Merck KGaA (70–230
mesh) was used for CC and TLC silica gel 60 F254 for analytical
and preparative TLC (both Merck KGaA). Spots on chromato-
grams were detected under UV light (254 and 365 nm) and by
anisaldehyde reagent stain.
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The herbal preparation, bottled in a deep yellow plastic con-
tainer (Fig. 1), was purchased from a known ‘muthi’ shop in the
Pietermaritzburg area of KwaZulu-Natal, with dates of manu-
facture and expiry indicated as 20/03/2005 and 03/2012 respec-
tively. According to the label material, the product was
formulated by T/Dr. Seth Seroka and traded under ‘Guideline
Trading’ of Alberton North. The product is indicated for symp-
tomatic relief of heartburn, constipation, stomach ache, loss of
appetite, vomiting and indigestion. Side effects may include a
mild fever during use, while the product is contra-indicated
for children and pregnant women. The recommended dosage
is one-quarter of a cup taken three times daily after meals. In-
gredients (each 125 mg) as listed per 125 mL are: Lesoko (Ale-
pidea amatymbica), Monnamaledu, Poo-tshehla, Setimamollo
(Pentanisia prunelloides), Mositsane (Elephantorrhiza ele-
phantina), deionized water (92.5% m/v), and 1.2% m/v potassi-
um sorbate as preservative. A warning is also issued on the
bottle label that the product should be kept out of reach of chil-
dren and stored below 25 °C away from contact with direct
sunlight.2.3. Extraction and isolation of di(2-ethylhexyl) phthalate
The herbal mixture (2×500 mL) was filtered through What-
man No.1 filter paper and subsequently freeze dried. The resul-
tant extract (4.1 g) was subjected to gravity column
chromatography over silica gel by gradient elution with hex-
ane/ethyl acetate and ethyl acetate/methanol mixtures. In this
manner, crude DEHP amounting to 170 mg was collected
from ten 50 mL fractions eluted with hexane/ethyl acetate
(80:20). Further purification was achieved via preparative
TLC using hexane/ethyl acetate (80:20) as developing solvent
to give DEHP (43.3 mg) as a colorless oil. The spectroscopic
data as shown below closely matched those that have been
reported for DEHP (Cohen et al., 1991).2.4. Physical and spectroscopic data for di(2-ethylhexyl)
phthalate
IR νMAX/cm
−1 (dry film): 2945, 1726, 1600, 1460, 1277,
1128, 1065, 750. HRMS (EI): calcd. 390.2770 for C24H38O4,
found 390.2778. LRMS (EI) 70 eV, m/z (rel. int.): 390 [M]+
(100), 337 (22), 277 [M-C8H17]
+ (8), 236 (15), 187 (26), 113
[C8H17]
+ (10). 1HNMR (400 MHz, CDCl3): δ 0.89 (6H, t,
J=6.84 Hz, H-6′), 0.92 (6H, t, J=7.48 Hz, H-8′), 1.46 (4H,
m, H-7′), 1.39 (4H, m, H-5′), 1.35 (4H, m, H-3′), 1.32 (4H,
m, H-4′), 1.67 (2H, m, H-2′), 4.20 (2H, dd, J=10.88,
6.12 Hz, H-1a′), 4.24 (2H, dd, J=10.92, 5.76 Hz, H-1b′),
7.52 (2H, dd, J=5.68, 3.32 Hz, H-4/H-5), 7.70 (2H, dd,
J=5.68, 3.32 Hz, H-3/H-6). 13CNMR (100 MHz, CDCl3): δ
11.3 (q, C-8′), 14.4 (q, C-6′), 23.3 (t, C-5′), 24.1 (t, C-7′),
29.3 (t, C-4′), 30.7 (t, C-3′), 39.1 (d, C-2′), 68.5 (t, C-1′),
129.1 (d, C-3/C-6), 131.2 (d, C-4/C-5), 132.8 (s, C-1/C-2),
168.1 (s, CO).3. Results and discussion
Identification of the structure of di(2-ethylhexyl) phthalate
(DEHP) (Fig. 2) was based on spectroscopic data analysis. Infra-
red absorption bands at 1726 and 1600 cm−1 were indicative of
ester carbonyl and phenyl ring moieties, respectively. Dissocia-
tion of the molecule via electron impact (EI) showed the molec-
ular ion [M]+ peak as the base peak at m/z 390, correct for the
molecular mass of DEHP, with diagnostic fragment ions
detected atm/z 277 [M-C8H17]
+ and 113 [C8H17]
+. This was fur-
ther substantiated by HRMS analysis which gave a mass of
390.2778 g/mol for the compound, correct for the formula
C24H38O4 with calculated mass 390.2770 g/mol. The low field
region of the 1HNMR spectrum was populated by two resonance
signals, characteristic of an A2B2 spin system, in this case de-
rived from the aryl protons H-3/H-6 (δ 7.70, 2H, dd, J=5.68,
3.32 Hz) and H-4/H-5 (δ 7.52, 2H, dd, J=5.68, 3.32 Hz). 2D
proton-carbon HSQC analysis showed these protons to be corre-
lated to respective carbon signals at δ 129.1 (d, C-3/C-6) and
131.2 (d, C-4/C-5). The C-2′ oxygen-related methylene proton
signals were found further upfield in the 1HNMR spectrum at
δ 4.20 (2H, dd, J=10.88, 6.12 Hz, H-1a′) and 4.24 (2H, dd,
J=10.92, 5.76 Hz, H-1b′), correspondent with a carbon
resonance at δ 68.5 (t, C-1′). The C-2′ methine proton was
resonant at δ 1.67 (2H, m, H-2′) and had HSQC connectivity
to the carbon signal at δ 39.1 (d, C-2′). Both H-1′ and H-2′
were seen to share pronounced COSY contours with each
other, in accordance with their vicinal relationship, confirming
the branched nature of the alkyl chain of the ester as opposed
to the straight chain present in the isomeric dioctyl phthalate
(DOP). In addition, three-bond HMBC correlation clearly linked
H-1′ to the ester carbonyl (δ 168.1, s, CO), thus precluding the
possibility of the 1-methylheptyl ester isomer. Further signals
at δ 0.89 (6H, t, J=6.84 Hz, H-6′), 0.92 (6H, t, J=7.48 Hz,
H-8′), 1.46 (4H, m, H-7′), 1.39 (4H, m, H-5′), 1.35 (4H, m,
H-3′), and 1.32 (4H, m, H-4′), 1.67 (2H, m, H-2′) accounted
for the remaining methyl and methylene group protons of
DEHP. The 13CNMR spectrum also indicated the presence of
aryl ester carbonyl groups (δ 168.1, s, CO) and the C-1/C-2 qua-
ternary carbons (δ 132.8, s), thus accounting for the 24-carbon
skeleton of DEHP.
Phthalates are a well-known group of plasticizers used to
make polyvinyl chloride (PVC) plastic materials pliable
(Chen et al., 2004). Most PVC products contain DEHP plasti-
cizers in the range 30% to 80% by weight (Chen et al., 2004).
DEHP is found in products as diverse as construction materials,
consumer goods, medical products and packaging (Aignasse et
al., 1995). Since DEHP is not chemically bound to the plastic, it
poses a threat to the environment by readily leaching to the sur-
rounding medium or fluids (Chen et al., 2004). This is exacer-
bated by the fact that DEHP exhibits reproductive and
developmental toxicity, is carcinogenic and teratogenic, and
produces neurodegenerative effects in animal model studies
(Koch et al., 2006; Wittassek and Angerer, 2008). The most
striking effect of DEHP in short term toxicity studies is the pro-
liferation of hepatic peroxisomes, indicated by increased perox-
isomal enzyme activity and histopathological changes (Koch et
24 J.J. Nair et al. / South African Journal of Botany 80 (2012) 21–24al., 2006; Wittassek and Angerer, 2008). Furthermore, it has
been shown that DEHP is hydrolyzed enzymatically to
mono(2-ethylhexyl) phthalate (MEHP), which is known to be
even more toxic than the parent compound (Albro and
Lavenhar, 1989). Given the widespread usage of DEHP, its in-
herent toxic properties and the serious health risks it poses on a
global scale, organizations such as WHO have implemented
stringent guidelines pertaining to tolerable daily intake (TDI)
levels (WHO, 1996, 2003). In the case of DEHP, this has
been set at 8 μg/L for drinking water and 1.5 mg/kg of food
consumed. Based on the WHO drinking water guideline ratio
for DEHP, patients consuming ‘Sejeso’ herbal mixture at the
recommended dose (see experimental) would have an intake
of around 7.8 mg DEHP per day, in large excess of the levels
suggested for either water or food consumption. This level of
DEHP contamination in the mixture is alarming and highlights
the lack of effective control mechanisms within the informal
sector of TM trade in South Africa. Presumably, DEHP con-
tamination of the herbal remedy would have originated from
the plastic bottling material.
In summary, based on the promising pharmacological pro-
file of the commercially available ‘Sejeso’ preparation and its
cognate herbal constituents, a phytochemical investigation
was carried out to identify and quantify the active ingredients.
During the process, the common plasticizer material DEHP
was isolated at a concentration of 43.3 mg/L, which is seen to
be unacceptably high given its toxic nature as well as its restric-
tion via international regulatory guidelines. The prominence of
TM within the South African cultural landscape, its economic
potential as well as its anticipated integration into the main-
stream South African healthcare system, has benefits for all
players within the sector. However, for it to be a sustainable in-
dustry, a concerted effort is required to implement relevant
structures to ensure that the quality, safety and efficacy of
TMs are not compromised.
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